Pérez-López, F.R., Brincat, M., Tamer Erel, C., Tremollieres, F., Gambacciani, M., Lambrinoudaki, I., Moen, M.H., Schenck-Gustafsson, K., Vujovic, S., Rozenberg, S. and Rees, M. (2012) EMAS Position Statement: Vitamin D and Postmenopausal Health. Maturitas, 71, 83-88.
http://dx.doi.org/10.1016/j.maturitas.2011.11.002

has been cited by the following article:

• TITLE: Hypovitaminosis D and Associated Risk Factors in Postmenopausal Women

  AUTHORS: Ana M. Masoni, Inés Menoyo, Roberto Bocanera, Stella M. Pezzotto, Mario E. Morosano

  KEYWORDS: Vitamin D, Parathyroid Hormone, Post-Menopause, Vitamin D Deficiency

  JOURNAL NAME: Health, Vol.6 No.11, May 21, 2014

  ABSTRACT: Given the relevance of vitamin D in calcium metabolism homeostatic control, as well as its role as differentiation and cell proliferation modulator, it is important to study its circulating level in patients considered at risk, in order to develop prevention strategies. We studied 77 postmenopausal women with no history of osteoactive drug therapy, corticosteroid intake or diseases that could alter bone metabolism, attending the Menopause Center at the Hospital Provincial del Centenario, Rosario, Argentina. A medical history was taken, and a food consumption frequency questionnaire was applied in order to estimate daily calcium intake. To assess daily physical exercise, work and sports activities were investigated. Serum parathyroid hormone (PTH) and 25(OH)D were measured, and a hip DXA scan was performed in every patient. An inappropriate level of 25(OH)D was observed in 86.3% of patients. The 25(OH)D average value was found within the insufficiency range (